SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Newbury Pharmaceuticals reports Q4 operating cash flow of -5 105 TKR

Q4 operating cash flow was -5 105 TKR, compared with -5 004 TKR.

Related stories